Início › Linfoma Não Hodgkin › Oregon › Portland
Ensaios clínicos de Linfoma Não Hodgkin em Portland, OR
15 estudos para Linfoma Não Hodgkin estão buscando participantes em locais em Portland e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
RecrutandoFase 1/2
- Oregon Health and Sciences University, Portland
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecrutandoFase 2
- Providence Health & Services, Portland
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RecrutandoFase 1
- Oregon Health & Science University (OHSU), Portland
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RecrutandoFase 2
- Research Site, Portland
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
RecrutandoFase 2
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecrutandoFase 1/2
- Oregon Health & Science University, Portland
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RecrutandoEstudo observacional
- Oregon Health and Science University Knight Cancer Institute, Portland
DALY II USA/ MB-CART2019.1 for DLBCL
RecrutandoFase 2
- Oregon Health and Science University Knight Cancer Institute, Portland
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecrutandoEstudo observacional
- Oregon Health & Science University/Doernbecher Children's Hospital, Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RecrutandoFase 1/2
- Providence Neurological Specialties West, Portland
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecrutandoEstudo observacional
- Kaiser Permanente Northwest, Portland
Study of SGR-1505 in Mature B-Cell Neoplasms
RecrutandoFase 1
- Oregon Health and Science University - Knight Cancer Institute, Portland
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
RecrutandoEstudo observacional
- Local Institution - 0016, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Portland
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RecrutandoFase 1
- Oregon Health & Science University, Portland
Ensaios de Linfoma Não Hodgkin em outras cidades
- New York City, NY31 estudos
- Houston, TX31 estudos
- Boston, MA26 estudos
- Nashville, TN21 estudos
- Philadelphia, PA20 estudos
- Baldwin Park, CA19 estudos
- Washington, DC18 estudos
- Milwaukee, WI18 estudos
- Atlanta, GA18 estudos
- Chicago, IL18 estudos
- Columbus, OH18 estudos
- Dallas, TX17 estudos
Outros estudos em Portland
- Câncer de Pulmão de Não Pequenas Células46 estudos
- Câncer (todos os tipos)34 estudos
- Câncer de Mama33 estudos
- Câncer de Próstata33 estudos
- Câncer Metastático29 estudos
- Câncer Colorretal28 estudos
- Câncer de Ovário27 estudos
- Câncer de Pulmão26 estudos
- Leucemia Mieloide Aguda25 estudos
- Câncer Endometrial24 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço19 estudos
- Câncer de Pâncreas19 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.